Among the protective prognostic factors, high levels of ADAD1 have been reported to be strongly associated with the prognosis of colon cancer patients, and its improvement of patient prognosis may be associated with CD4+ T cells (Yang et al., 2020). This evidence concerns the gene ADAD1 and colonic neoplasm.